To detect whether STAT3 mediates PRRG4-enhanced mtDNA and ATP contents in breast cancer cells, we examined the effects of Stattic (a STAT3 inhibitor) treatment on MDA-MB-231 or HCC1954 cells overexpressing PRRG4-WT. The gene discussed is STAT3; the disease is breast carcinoma.